What Is Selank? A Research Guide to the Anxiolytic Peptide

If you have been reading about nootropic peptides, you have almost certainly encountered Selank alongside its better-known sibling Semax. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, but they target fundamentally different aspects of brain function. Where Semax focuses on cognition and neuroprotection, Selank targets anxiety and stress regulation -- without the sedation, dependence, or cognitive impairment associated with traditional anxiolytics like benzodiazepines.

This guide covers what Selank is, how it works, what the clinical data shows, and where to find the best prices for research.

---

What Is Selank?

Selank is a synthetic heptapeptide (seven amino acids) derived from tuftsin -- an endogenous immunomodulatory peptide naturally produced by enzymatic cleavage of the heavy chain of immunoglobulin G (IgG). The core tuftsin sequence (Thr-Lys-Pro-Arg) was extended with a stabilizing Pro-Gly-Pro tail to create Selank, extending its biological half-life and enhancing its neurotropic properties.

Selank is approved in Russia for the treatment of generalized anxiety disorder (GAD) and neurasthenia. It is administered intranasally, similar to Semax.

Despite its origin from an immune peptide, Selank's primary clinical applications are neurological. Its anxiolytic properties are the focus of its regulatory approval and most of its published research.

View the full Selank research profile and compare vendor prices on PeptidePrices.

---

How Does Selank Work?

Selank modulates anxiety through several complementary pathways, which together produce anxiolysis without the mechanistic liabilities of GABAergic drugs like benzodiazepines.

GABAergic gene expression. A 2016 study in Frontiers in Pharmacology (PMID: 26924987) demonstrated that Selank affects the expression of genes involved in GABAergic neurotransmission. Rather than directly binding GABA receptors (as benzodiazepines do), Selank modulates the upstream genetic regulation of the GABA system -- a subtler intervention that may explain the absence of sedation and tolerance.

Enkephalin-degrading enzyme inhibition. Selank inhibits enzymes that break down enkephalins -- the body's endogenous opioid peptides involved in pain modulation and emotional regulation (Bulletin of Experimental Biology & Medicine, 2001, PMID: 11550013). By extending the activity of these natural peptides, Selank may contribute to mood stabilization and stress resilience.

BDNF upregulation. Like Semax, Selank has been shown to increase brain-derived neurotrophic factor expression in the hippocampus (2019, PMID: 31625062). BDNF supports neuronal plasticity, which is relevant to both anxiety regulation and the brain's ability to adapt to stress.

Cytokine modulation. Reflecting its tuftsin heritage, Selank influences cytokine balance under conditions of immune stress (2020, PMID: 32621722). This immunomodulatory activity has led to research interest in stress-related immune dysregulation -- a recognized clinical phenomenon in which chronic anxiety suppresses immune function.

---

What Does the Research Say?

Generalized anxiety disorder. A clinical trial published in Zhurnal Nevrologii (2008, PMID: 18454096) evaluated Selank in patients with generalized anxiety disorder and neurasthenia. The study reported anxiolytic efficacy comparable to standard treatments, forming the basis for its Russian regulatory approval.

Comparison to benzodiazepines. A 2014 study (PMID: 25176261) directly compared Selank to phenazepam (a benzodiazepine widely used in Russia) in anxiety patients. Selank demonstrated comparable anxiolytic effects without the sedation, cognitive impairment, or dependence risk associated with benzodiazepine therapy. This finding is significant because benzodiazepine alternatives that genuinely lack dependence potential are rare in pharmacology.

Preclinical stress models. In a 2017 study using an unpredictable chronic mild stress (UCMS) model in rats (PMID: 28280289), Selank enhanced the effects of diazepam -- suggesting it could potentiate the activity of existing anxiolytics, potentially allowing lower doses and reduced side effects.

Memory and ethanol-related impairment. A 2019 study found that Selank protected against ethanol-induced memory impairment in rats, an effect mediated through BDNF expression in the hippocampus (PMID: 31625062).

The full citation list is available in the PeptidePrices research library.

---

Selank Safety Profile

PeptidePrices assigns Selank a safety rating of 7 out of 10. It is approved in Russia with a clinical track record that includes no reports of sedation, amnesia, or physical dependence -- the three most problematic side effects of conventional anxiolytics. The intranasal delivery route is non-invasive and well-tolerated.

Limitations include a relatively small Western clinical evidence base and the absence of FDA or EMA regulatory review. The Russian clinical data is peer-reviewed but has not been replicated in large-scale international trials.

---

Selank vs. Similar Compounds

• Semax was developed by the same institute but focuses on cognition and neuroprotection rather than anxiety. Semax is ACTH-derived; Selank is tuftsin-derived. They are often researched in combination.
• Diazepam and other benzodiazepines are the pharmacological standard for acute anxiety. Effective but carry well-documented risks of tolerance, dependence, and cognitive impairment that Selank appears to avoid.
• KPV is an alpha-MSH fragment with anti-inflammatory properties. While KPV modulates inflammation (including neuroinflammation), it is not primarily anxiolytic.
• L-Theanine is a naturally occurring amino acid with mild anxiolytic effects. Much weaker mechanism than Selank's multi-pathway approach but available as a dietary supplement.

Selank is distinctive as an anxiolytic peptide with clinical approval, no dependence signal, and a multi-target mechanism spanning GABA regulation, enkephalin modulation, and neurotrophin support.

---

Dosing in Research Settings

The following is for informational purposes only and does not constitute medical advice.

In its approved Russian formulation, Selank is delivered intranasally at a 0.15% solution. Typical clinical protocols involve 2-3 drops per nostril administered 2-3 times daily, with treatment courses lasting 10-14 days. Some protocols describe longer courses depending on the clinical indication.

No Western clinical dosing guidelines exist. Any protocols encountered outside of Russian clinical literature are extrapolated and have not been validated by FDA-equivalent regulatory review.

---

Comparing Selank Prices

Like Semax, Selank is available from research vendors in both nasal spray and lyophilized powder forms. Pricing varies significantly across vendors and product formats, making per-milligram normalization essential for fair comparison.

PeptidePrices normalizes pricing across 19+ vendors to a per-milligram basis.

See the live Selank price comparison across all vendors.

The AI Stack Builder can help you explore anxiolytic and nootropic protocol combinations if you are building a multi-compound research protocol.

---

Wrapping Up

Selank is one of the rare research peptides with genuine clinical approval and a favorable comparison to established pharmaceutical anxiolytics. Its mechanism -- spanning GABAergic gene regulation, enkephalin modulation, BDNF upregulation, and cytokine balancing -- provides anxiolysis without the sedation, tolerance, or dependence that limit benzodiazepine utility. The Western evidence base remains thin, but the Russian clinical program and published data provide a stronger foundation than most research peptides offer.

If you are researching Selank, review the published clinical comparisons, understand the legal situation in your jurisdiction, and compare vendor prices carefully.

Compare Selank prices across all vendors at PeptidePrices -- find the best price in seconds.

---

For research purposes only. Not for human consumption. Not medical advice. Always consult a qualified healthcare provider before making any health or supplementation decisions.